SearchDictionaryMobileLogin

Cesarean Section (Caesarean Section)

8377  relevant articles (207 outcomes, 598 trials/studies) found for this Therapy

Description: Extraction of the FETUS by means of abdominal HYSTEROTOMY.

Also Known As:
Caesarean Section; C-Section (OB); Postcesarean Section; Abdominal Deliveries; C Section (OB); C-Sections (OB); Caesarean Sections; Cesarean Sections; Deliveries, Abdominal; Abdominal Delivery; Delivery, Abdominal

Relationship Network

Therapy Context: Research Results

Experts

1. Sharma, J B: 5 articles (08/2006 - 01/2003)
2. Palacio, F J: 4 articles (06/2008 - 08/2004)
3. Jokubkiene, L: 3 articles (08/2008 - 08/2008)
4. Vikhareva Osser, O: 3 articles (08/2008 - 08/2008)
5. Valentin, L: 3 articles (08/2008 - 08/2008)
6. Fornet, I: 3 articles (06/2008 - 12/2007)
7. López, M A: 3 articles (06/2008 - 12/2007)
8. Seo, Norimasa: 3 articles (02/2008 - 06/2002)
9. Fukuda, Isao: 3 articles (01/2008 - 03/2004)
10. Kuczkowski, K M: 3 articles (01/2008 - 07/2002)

Related Diseases

1. Infection
2. Fetal Distress
08/01/2005 - "RESULTS: The amnioinfusion group showed a significant reduction in the rate of cesarean section for fetal distress (relative risk [RR], 0.7; 95% confidence interval [CI], 0.6-0.83), and a 30% reduction in abnormal fetal heart rate patterns (RR, 0.7; 95% CI, 0.6-0.83)"
06/01/1998 - "RESULTS: The total population showed no statistical difference in outcome parameters between groups 1 and 2. However, a subgroup of patients evaluated for suspected uteroplacental insufficiency did show a significant reduction in caesarean section for fetal distress in group 2 patients"
05/01/1997 - "External version compared to breech extraction was associated with a significantly greater incidence of cesarean section (8/33 vs. 1/43, P = .008) and fetal distress (8/33 vs. 1/43, P = .008)"
05/01/1995 - "Meta-analysis shows a significant reduction in the number of antenatal admissions (44%, 95% confidence interval 28% to 57%), inductions of labor (20%, 95% confidence interval 10% to 28%), and cesarean sections for fetal distress (52%, 95% confidence interval 24% to 69%) in the Doppler group and that the clinical action guided by Doppler ultrasonography reduces the odds of perinatal death by 38% (95% confidence interval 15% to 55%)"
04/01/1989 - "There was significantly greater (p less than .05) morbidity in group 2 compared to group 1 as judged by cesarean section for fetal distress (47% vs 15%), meconium at delivery (53% vs 4%), and 5-minute Apgar score less than 7 (30% vs 4%)"
Order ALL the reference details at left...
3. Endometritis
4. Dystocia
5. Pain (Aches)

Related Drugs and Biologics

1. Morphine (MS Contin)
2. Bupivacaine (Bupivacaine Hydrochloride)
3. Anti-Bacterial Agents (Antibiotics)
4. Ephedrine
5. Granisetron (Kytril)
6. Cefoxitin (Cefoxitin Sodium)
7. Cefotetan (Cefotan)
8. Droperidol
9. Propofol (Diprivan)
10. Metronidazole (Metric)

Related Therapies and Procedures

1. Analgesia
2. Spinal Anesthesia
3. Epidural Anesthesia
4. Hysterectomy
5. Antibiotic Prophylaxis

Best Treatments:
Research Summary Report
on Infection

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 13878 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>